Navigation Links
Medbox, Inc. Announces New Board of Directors After Acquisition of Prescription Vending Machines, Inc.
Date:12/19/2011

HOLLYWOOD, Calif., Dec. 19, 2011 /PRNewswire/ -- Medbox, Inc. (Ticker: MDBX) (www.medboxinc.com) today announced their newly appointed officers and directors after their acquisition of Prescription Vending Machines, Inc. (PVM).

PVM's Founder and CEO, Vincent Mehdizadeh, commented on his fellow appointees by stating, "I am thrilled to have such dynamic individuals on our team, which are comprised of Doctorates and MBAs. We are entering a period of rapid growth and the expertise of this team will help steer the company, set important policies, and establish a solid foundation that will support our expansion from a mid-size company to an international leader in our field." Mr. Mehdizadeh went on to state, "Since PVM is a profitable company with a solid management team, we wanted to implement PVM's officers in key positions within Medbox, Inc."

Effective December 1, 2011, the new Executive Management Team for Medbox, Inc. is as follows:

Vincent Mehdizadeh, Board Member (CEO and Founder, PVM)
Dr. Bruce Bedrick, President, Director, Board Member (COO, PVM)
Leila Guieb, Treasurer, Director, Board Member (CFO, PVM)
Christine Collins, Secretary, Director
Angelique Dolan, Board Member (Director of Marketing, PVM)

For more information on Medbox, Inc. please call the Investor Relations Department at (800) 766-1452 or go online to www.medboxinc.com

Medbox is a publicly traded company, with its stock listed on the OTC Board, ticker symbol MDBX.

About Medbox: 
Medbox is a leader in the development, sales and service of automated, biometrically controlled, dispensing and storage systems for medicine. The company also features automated, biometrically controlled, mini-storage units for other valuables. Medbox has offices throughout the world, including New York, Tokyo, Toronto, with corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, clinics, hospitals, and medical groups worldwide.

 

 


'/>"/>
SOURCE Medbox, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Biophysical Society announces speakers for Future of Biophysics Burroughs Wellcome Fund Symposium
2. Fate Therapeutics Announces Promising Data From Phase 1b Study of ProHema at the 2011 American Society of Hematology Annual Conference
3. DigitalPersona Announces FingerJet OEM Fingerprint Recognition Software for Biometric Device Manufacturers and Solution Providers
4. Biophysical Society Announces winners of 2012 International Relations Committee travel awards
5. Biophysical Society announces winners of 2012 CPOW travel awards
6. EpiGen announces collaboration with Nestlé
7. Minister announces UK-India collaboration on bioenergy
8. BGI announces collaborative research agreements with Oregon State University
9. NIH TRND program announces next round of drug development projects
10. DigitalPersona Announces FingerJet OEM Fingerprint Recognition Software for Biometric Device Manufacturers and Solution Providers
11. BGI announces collaboration with Johns Hopkins University on synthetic yeast project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... , February 7, 2017 Ipsidy ... Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a ... transaction processing services, is pleased to announce the following ... Effective January 31, 2017, Philip D. ... Directors, CEO and President.  An experienced payment industry professional ...
(Date:2/3/2017)... 2017  Texas Biomedical Research Institute announced that its Board ... as the Institute,s new President and CEO. Dr. Schlesinger ... 2017. He is currently the Chair of the Department of ... Microbial Interface Biology at Ohio State University. "We ... and CEO of Texas Biomed," said Dr. James O. ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Feb. 16, 2017 Research and ... Biology: Global Markets" report to their offering. ... ... genes, biobrick parts, delivery plasmids, chassis organisms, synthetic cells, ... assembly, genome editing, bioinformatics and specialty media) and enabled ...
(Date:2/16/2017)... HOLLISTON, Mass. , Feb. 16, 2017   ... or the "Company"), a biotechnology company developing bioengineered organ ... the esophagus, bronchus and trachea, announced today the closing ... offering of 20,000,000 shares of common stock and warrants ... gross proceeds of $8.0 million. The offering was priced ...
(Date:2/16/2017)... , Feb. 16, 2017 UCHealth ( ... utilize LungDirect for pulmonary nodule patient management. In addition ... or a spot on the lung, UCHealth looks to ... manual data entry. Stephanie Brown, RN ... my nodule patients with an Excel spreadsheet, which was ...
(Date:2/16/2017)... 2017  Champions Oncology, Inc. (NASDAQ: CSBR ... of advanced technology solutions and products to personalize the ... addition of new cohorts of PDX models to their ... expand Champions, product line in hepatocellular cancer, breast cancer, ... and non-small cell lung cancer (including EGFR mutation; ALK/ROS1 ...
Breaking Biology Technology: